https://orcid.org/0000-0002-3297-3996
Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Seung-Woo Kim, Chan Woo Kim & Hong Seok Kim. (2024) Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation. Animal Cells and Systems 28:1, pages 55-65.
Read now
Read now
Yaruq Jabeen, Numan Yousaf, Mohd Sani Sarjadi, Jualang Azlan Gansau & Lucky Poh Wah Goh. (2023) Bioactive compounds derived from marine source: a potential immunotherapy treatment. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Read now
Nina Jiang, Ye Hu, Meiling Wang, Zuowei Zhao & Man Li. (2022) The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer. Breast Cancer: Targets and Therapy 14, pages 291-309.
Read now
Read now
Nicola Silvestris, Antonella Argentiero, Oronzo Brunetti, Margherita Sonnessa, Fulvia Colonna, Sabina Delcuratolo, Claudio Luchini, Aldo Scarpa, Sara Lonardi, Floriana Nappo, Matteo Fassan, Antonio Giovanni Solimando, Livia Fucci & Concetta Saponaro. (2021) PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study. Expert Opinion on Therapeutic Targets 25:11, pages 1007-1016.
Read now
Read now
Articles from other publishers (50)
Shan-Yong Yi, Mei-Zhuo Wei & Ling Zhao. (2024) Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy. Critical Reviews in Oncology/Hematology 196, pages 104313.
Crossref
Crossref
Krishna Mahanti & Sankar Bhattacharyya. (2024) Rough neighborhood: Intricacies of cancer stem cells and infiltrating immune cell interaction in tumor microenvironment and potential in therapeutic targeting.. Translational Research 265, pages 51-70.
Crossref
Crossref
Man Wang, Fei Yu, Yuan Zhang & Peifeng Li. (2024) Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy. Frontiers in Immunology 15.
Crossref
Crossref
Jingjing Hu, Ke Chen, Fangfang Hong, Guosheng Gao, Xiaoyu Dai & Hua Yin. (2023) METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway. Cancer Gene Therapy 31:2, pages 228-236.
Crossref
Crossref
Hao Ling, Qinyi Zhang, Qiuhua Luo, Defang Ouyang, Zhonggui He, Jin Sun & Mengchi Sun. (2024) Dynamic immuno-nanomedicines in oncology. Journal of Controlled Release 365, pages 668-687.
Crossref
Crossref
Amy Thomas, Nishtha Pathak, Leah Moses & Gnanasekar Munirathinam. 2024. Cancer Stem Cells and Signaling Pathways. Cancer Stem Cells and Signaling Pathways
549
579
.
E. Yu. Zubareva, M. A. Senchukova, T. A. Karmakova & N. V. Zaitsev. (2023) The features of PD-L1 expression in tumor stromal cells, peritumoral microvessels and isolated clusters of tumor cells in breast cancer tissue and their correlation with clinical and morphological characteristics of breast cancer. Siberian journal of oncology 22:5, pages 71-83.
Crossref
Crossref
Su-Lim Kim, Hack Sun Choi & Dong-Sun Lee. (2023) BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells. Cell Communication and Signaling 21:1.
Crossref
Crossref
Plaboni Sen & Siddhartha Sankar Ghosh. (2023) γ-Secretase Inhibitor Potentiates the Activity of Suberoylanilide Hydroxamic Acid by Inhibiting Its Ability to Induce Epithelial to Mesenchymal Transition and Stemness via Notch Pathway Activation in Triple-Negative Breast Cancer Cells. ACS Pharmacology & Translational Science 6:10, pages 1396-1415.
Crossref
Crossref
Blanca Estela García-Pérez, Christian Pérez-Torres, Shantal Lizbeth Baltierra-Uribe, Juan Castillo-Cruz & Nayeli Shantal Castrejón-Jiménez. (2023) Autophagy as a Target for Non-Immune Intrinsic Functions of Programmed Cell Death-Ligand 1 in Cancer. International Journal of Molecular Sciences 24:19, pages 15016.
Crossref
Crossref
Caecilia Sukowati, Loraine Kay D. Cabral, Beatrice Anfuso, Francesco Dituri, Roberto Negro, Gianluigi Giannelli & Claudio Tiribelli. (2023) PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma. International Journal of Molecular Sciences 24:17, pages 13357.
Crossref
Crossref
Noha A. Selem, Heba Nafae, Tamer Manie, Rana A. Youness & Mohamed Z. Gad. (2023) Let-7a/cMyc/CCAT1/miR-17–5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1. Pathology - Research and Practice 248, pages 154579.
Crossref
Crossref
Argha Mario Mallick, Abhijit Biswas, Sukumar Mishra, Sonali Jadhav, Kasturee Chakraborty, Archana Tripathi, Arnab Mukherjee & Rituparna Sinha Roy. (2023) Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer. Chemical Science 14:29, pages 7842-7866.
Crossref
Crossref
Sunny Kumar, Mouli Chatterjee, Pratyasha Ghosh, Kirat K. Ganguly, Malini Basu & Mrinal K. Ghosh. (2023) Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. Genes & Diseases 10:4, pages 1318-1350.
Crossref
Crossref
Ivan Lučić, Matea Kurtović, Monika Mlinarić, Nikolina Piteša, Ana Čipak Čipak Gašparović, Maja Sabol & Lidija Milković. (2023) Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches. International Journal of Molecular Sciences 24:13, pages 10683.
Crossref
Crossref
Maximilian Haist, Justus Kaufmann, Ivan-Maximiliano Kur, Stefanie Zimmer, Stephan Grabbe, Heinz Schmidberger, Andreas Weigert & Arnulf Mayer. (2023) Response to primary chemoradiotherapy of locally advanced oropharyngeal carcinoma is determined by the degree of cytotoxic T cell infiltration within tumor cell aggregates. Frontiers in Immunology 14.
Crossref
Crossref
Yoshinori Abe, Takumi Sano & Nobuyuki Tanaka. (2023) The Role of PRMT5 in Immuno-Oncology. Genes 14:3, pages 678.
Crossref
Crossref
Katarzyna Starska-Kowarska. (2023) The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. Cancers 15:6, pages 1642.
Crossref
Crossref
Nhat-Chau TRUONG, Nhi-Thao HUYNH, Kmuong-Duy PHAM & Phuc-Van PHAM. (2023) Roles of cancer stem cells in cancer immune surveillance. Minerva Biotechnology and Biomolecular Research 35:1.
Crossref
Crossref
Yoel Genaro Montoyo-Pujol, Marta García-Escolano, José J. Ponce, Silvia Delgado-García, Tina Aurora Martín, Hortensia Ballester, Elena Castellón-Molla, Pascual Martínez-Peinado, Sandra Pascual-García, José Miguel Sempere-Ortells & Gloria Peiró. (2023) Variable Intrinsic Expression of Immunoregulatory Biomarkers in Breast Cancer Cell Lines, Mammospheres, and Co-Cultures. International Journal of Molecular Sciences 24:5, pages 4478.
Crossref
Crossref
Evgenia Zubareva, Marina Senchukova & Tatyana Karmakova. (2023) Predictive significance of HIF-1α, Snail, and PD-L1 expression in breast cancer. Clinical and Experimental Medicine 23:6, pages 2369-2383.
Crossref
Crossref
Sayali S. Onkar, Neil M. Carleton, Peter C. Lucas, Tullia C. Bruno, Adrian V. Lee, Dario A.A. Vignali & Steffi Oesterreich. (2023) The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes. Cancer Discovery 13:1, pages 23-40.
Crossref
Crossref
Wenwen Guo, Tianyun Qiao & Tian Li. (2022) The role of stem cells in small-cell lung cancer: Evidence from chemoresistance to immunotherapy. Seminars in Cancer Biology 87, pages 160-169.
Crossref
Crossref
Dae Young Lee, Eunji Im, Dahye Yoon, Young-Seob Lee, Geum-Soog Kim, Donghwi Kim & Sung-Hoon Kim. (2022) Pivotal role of PD-1/PD-L1 immune checkpoints in immune escape and cancer progression: Their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals. Seminars in Cancer Biology 86, pages 1033-1057.
Crossref
Crossref
Ming Shen, Chuanrong Chen, Qianqian Guo, Quan Wang, Jinghan Liao, Liting Wang, Jian Yu, Man Xue, Yourong Duan & Jiali Zhang. (2022) Systemic Delivery of mPEG‐Masked Trispecific T‐Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect. Advanced Science 9:32.
Crossref
Crossref
Hui Xu, Fengxia Zhang, Xiaokang Gao, Qiwang Zhou & Linhai Zhu. (2022) Fate decisions of breast cancer stem cells in cancer progression. Frontiers in Oncology 12.
Crossref
Crossref
Shiao Y. ChowAsier Unciti-Broceta. (2022) Targeted Molecular Construct for Bioorthogonal Theranostics of PD-L1-Expressing Cancer Cells. JACS Au 2:7, pages 1747-1756.
Crossref
Crossref
Chin-Lin Guo. (2022) Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Mohsen Soltanshahi, Saeid Taghiloo & Hossein Asgarian-Omran. (2022) Expression Modulation of Immune Checkpoint Molecules by Ibrutinib and Everolimus Through STAT3 in MCF-7 Breast Cancer Cells. Iranian Journal of Pharmaceutical Research 21:1.
Crossref
Crossref
Constanze Banz-Jansen, Laureen P. Helweg & Barbara Kaltschmidt. (2022) Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?. International Journal of Molecular Sciences 23:6, pages 3412.
Crossref
Crossref
Taniya Saha & Kiven Erique Lukong. (2022) Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. Frontiers in Oncology 12.
Crossref
Crossref
Tianshu Zhang, Huimin Zhou, Kexin Wang, Xiaowei Wang, Mengyan Wang, Wenxia Zhao, Xiaoming Xi, Yang Li, Meilian Cai, Wuli Zhao, Yanni Xu & Rongguang Shao. (2022) Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development. Biomedicine & Pharmacotherapy 147, pages 112616.
Crossref
Crossref
Lingchen Fu, Jia Fan, Sudipa Maity, Grant McFadden, Yixin Shi & Wei Kong. (2022) PD-L1 interacts with Frizzled 6 to activate β-catenin and form a positive feedback loop to promote cancer stem cell expansion. Oncogene 41:8, pages 1100-1113.
Crossref
Crossref
Qianyi Gong, Hua Yu, Guiqing Ding, Jinyun Ma, Yuanhua Wang & Xiaodong Cheng. (2022) Suppression of stemness and enhancement of chemosensibility in the resistant melanoma were induced by Astragalus polysaccharide through PD-L1 downregulation. European Journal of Pharmacology 916, pages 174726.
Crossref
Crossref
Sarthak Sahoo, Sonali Priyadarshini Nayak, Kishore Hari, Prithu Purkait, Susmita Mandal, Akash Kishore, Herbert Levine & Mohit Kumar Jolly. (2021) Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype. Frontiers in Immunology 12.
Crossref
Crossref
Morgan Brisset, Mélodie Grandin, Agnès Bernet, Patrick Mehlen & Frédéric Hollande. (2021) Dependence receptors: new targets for cancer therapy. EMBO Molecular Medicine 13:11.
Crossref
Crossref
Binjie Huang, Xin Yan & Yumin Li. (2021) Cancer Stem Cell for Tumor Therapy. Cancers 13:19, pages 4814.
Crossref
Crossref
Laura Gramantieri, Catia Giovannini, Fabrizia Suzzi, Ilaria Leoni & Francesca Fornari. (2021) Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers. Cancers 13:18, pages 4550.
Crossref
Crossref
Yamin Liang, Lu Li, Yanmei Chen, Jinyan Xiao & Dangheng Wei. (2021) PD-1/PD-L1 immune checkpoints: Tumor vs atherosclerotic progression. Clinica Chimica Acta 519, pages 70-75.
Crossref
Crossref
Caecilia H C Sukowati, Korri Elvanita El-Khobar & Claudio Tiribelli. (2021) Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells. World Journal of Stem Cells 13:7, pages 795-824.
Crossref
Crossref
Juntao Li, Dan Qi, Tze-Chen Hsieh, Jason H. Huang, Joseph M. Wu & Erxi Wu. (2021) Trailblazing perspectives on targeting breast cancer stem cells. Pharmacology & Therapeutics 223, pages 107800.
Crossref
Crossref
Martina Mang Leng Lei & Terence Kin Wah Lee. (2021) Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Mengxi Xiu, Yongbo Wang, Baoli Li, Xifeng Wang, Fan Xiao, Shoulin Chen, Lieliang Zhang, Bin Zhou & Fuzhou Hua. (2021) The Role of Notch3 Signaling in Cancer Stemness and Chemoresistance: Molecular Mechanisms and Targeting Strategies. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Gang Nie, Xiangbo Cao, Yan Mao, Zhidong Lv, Meng Lv, Yongmei Wang, Haibo Wang & Chen Liu. (2021) Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin. International Immunopharmacology 95, pages 107153.
Crossref
Crossref
Yuce Li, Jun Xie, Wooram Um, Dong Gil You, Seunglee Kwon, Lianbin Zhang, Jintao Zhu & Jae Hyung Park. (2020) Sono/Photodynamic Nanomedicine‐Elicited Cancer Immunotherapy. Advanced Functional Materials 31:12.
Crossref
Crossref
Zhanghao Huang, Muqi Shi, Hao Zhou, Jinjie Wang, Hai-Jian Zhang & Jia -Hai Shi. (2021) Prognostic signature of lung adenocarcinoma based on stem cell-related genes. Scientific Reports 11:1.
Crossref
Crossref
Peiwen Chen, Wen-Hao Hsu, Jincheng Han, Yan Xia & Ronald A. DePinho. (2021) Cancer Stemness Meets Immunity: From Mechanism to Therapy. Cell Reports 34:1, pages 108597.
Crossref
Crossref
Priya Veluswamy, Max Wacker, Maximilian Scherner & Jens Wippermann. (2020) Delicate Role of PD-L1/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance. International Journal of Molecular Sciences 21:21, pages 8159.
Crossref
Crossref
Siyuan Qin, Jingwen Jiang, Yi Lu, Edouard C. Nice, Canhua Huang, Jian Zhang & Weifeng He. (2020) Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
PamungkasBagus Satriyo, Chi-Tai Yeh, Jia-Hong Chen, Teguh Aryandono, SofiaMubarika Haryana & Tsu-Yi Chao. (2020) Dual therapeutic strategy targeting tumor cells and tumor microenvironment in triple-negative breast cancer. Journal of Cancer Research and Practice 7:4, pages 139.
Crossref
Crossref